Justin M. Hall Esq.
Net Worth

Last updated:

What is Justin M. Hall Esq. net worth?

The estimated net worth of Mr. Justin M. Hall Esq. is at least $2,579,957 as of 14 Sep 2022. He owns shares worth $79,687 as insider, has earned $95,950 from insider trading and has received compensation worth at least $2,404,320 in NovaBay Pharmaceuticals, Inc..

What is the salary of Justin M. Hall Esq.?

Mr. Justin M. Hall Esq. salary is $400,720 per year as Pres, Chief Executive Officer, Gen. Counsel, Chief Compliance Officer, Corporation Sec. & Director in NovaBay Pharmaceuticals, Inc..

How old is Justin M. Hall Esq.?

Mr. Justin M. Hall Esq. is 47 years old, born in 1978.

What stocks does Justin M. Hall Esq. currently own?

As insider, Mr. Justin M. Hall Esq. owns shares in one company:

Company Title Shares Price per share Total value
NovaBay Pharmaceuticals, Inc. (NBY) Pres, Chief Executive Officer, Gen. Counsel, Chief Compliance Officer, Corporation Sec. & Director 83,172 $0.96 $79,687

What does NovaBay Pharmaceuticals, Inc. do?

NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.

Justin M. Hall Esq. insider trading

NovaBay Pharmaceuticals, Inc.

Mr. Justin M. Hall Esq. has made only one insider trade between 2019-2022, according to the Form 4 filled with the SEC. He purchased 10,000 units of NBY stock worth $1,500 on 14 Sep 2022.

As of 14 Sep 2022 he still owns at least 83,172 units of NBY stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 10,000 $0.15 $1,500
Purchase
Common Stock 69,767 $0.43 $30,000
Sale
Common Stock 47,500 $2.02 $95,950

NovaBay Pharmaceuticals key executives

NovaBay Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: